BEUDAMED
    FDA Adverse Event Injury Summary report: N

    HEMOLUNG RAS

    MDR report key: 16200112 · Received January 18, 2023

    Report

    Report Number
    3009763347-2023-00068
    Event Type
    Injury
    Date Received
    January 18, 2023
    Date of Event
    April 13, 2020
    Report Date
    January 18, 2023
    Manufacturer
    ALUNG TECHNOLOGIES, INC.
    Product Code
    QOH
    UDI-DI
    00850046004346
    PMA / PMN Number
    DEN210006
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    PA, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    PATIENT INFORMATION WAS NOT PROVIDED. ALUNG TECHNOLOGIES, INC. MANUFACTURES THE HEMOLUNG RAS AND CATHETER. THE INCIDENT OCCURRED IN PITTSBURGH, PENNSYLVANIA. AN ADVERSE EVENT WAS REPORTED IN WHICH THE SUBJECT EXPERIENCED THROMBOCYTOPENIA AFTER HEMOLUNG THERAPY. THE DATA LOG FROM THERAPY HAS BEEN RETRIEVED AND REVIEWED BY BOTH CLINICAL AND SOFTWARE ENGINEERING STAFF. NO ABNORMALITIES WERE NOTED WITHIN THE CO2 REMOVAL AND BLOOD FLOW GRAPHS. THE ALARMS OBSERVED WERE IN RESPONSE TO THE CONTROLLER BEHAVING AS INTENDED. CLINICAL AND TECHNICAL SUPPORT WERE PROVIDED AND CONTROLLER SWITCHES WERE PERFORMED ACCORDINGLY WITHOUT ISSUE. THERAPY WAS PROVIDED AS INTENDED. NO CAPA WAS OPENED BECAUSE OF THIS EVENT. THROMBOCYTOPENIA IS A KNOWN POSSIBLE COMPLICATION ASSOCIATED WITH USE OF EXTRACORPOREAL THERAPY. EXAMINATION OF THE CONTROLLER DATA LOG SHOWS THAT THERAPY WAS PROVIDED AS INTENDED. ALUNG TECHNOLOGIES, INC. WILL CONTINUE TO MONITOR ANY ISSUES AS THEY ARE REPORTED. THIS MDR IS BEING FILED IN RESPONSE TO A RETROSPECTIVE VIEW OF ALL ALUNG TECHNOLOGIES, INC. COMPLAINTS, WHICH IDENTIFIED THAT THE REPORTING DECISION FOR THIS COMPLAINT WAS NOT CORRECT. THIS MDR IS BEING FILED RETROSPECTIVELY TO CORRECT THE ERROR IN THE REPORTING DECISION

    Description of Event or Problem · 0

    ALUNG TECHNOLOGIES, INC. RECEIVED A REPORT THAT AFTER HEMOLUNG THERAPY, THE PATIENT EXPERIENCED THROMBOCYTOPENIA.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    129490 HEMOLUNG RAS EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL QOH ALUNG TECHNOLOGIES, INC. HL-CR4-01-000 00850046004346

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Other